Money, money, money Money, money, money It used to require hundreds of thousands of patients taking a drug to make it blockbuster. But…
Is that for me? Is that for me? The Boston Globe devoted its top story this morning to criticizing Vertex Pharmaceuticals for…
Patient Satisfaction: Behind the Buzzword Patient satisfaction seems to be a major buzzword in healthcare, and with good reason: with the move…
When Americans talk, pharmaceutical companies listen. When Americans talk, pharmaceutical companies listen. And what they’ve heard is that initiatives to contain or regulate medical costs get…
As the pharmaceutical industry faces increasing pressure to be more patient-centric, ensuring sufficient focus on the ultimate end consumer for medicines is…
Sovaldi: An Example of Price Discrimination
3 Mins read
The controversy over the pricing of Gilead’s Sovaldi for Hepatitis C is a textbook example of price discrimination in action. I hope that my…
The Buzz About Specialty Pharmacy If you’ve been hearing a lot of buzz about “specialty drugs” and “specialty pharmacies” you might be wondering…
So far this year there has been a lot in the news about M&A activity within the pharmaceutical industry, and lately the…
Last week’s news about Pfizer’s $17 billion deal to acquire Hospira, a leading generic injectibles and biosimilars company, shows some of the…